Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2002 1
2003 3
2005 1
2006 1
2007 1
2008 1
2009 1
2010 1
2011 1
2012 3
2013 3
2014 3
2015 3
2016 6
2017 8
2018 10
2019 6
2020 13
2021 6
2022 5
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Prodrugs: design and clinical applications.
Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, Järvinen T, Savolainen J. Rautio J, et al. Among authors: heimbach t. Nat Rev Drug Discov. 2008 Mar;7(3):255-70. doi: 10.1038/nrd2468. Nat Rev Drug Discov. 2008. PMID: 18219308 Review.
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection.
Matthews RP, Zang X, Barrett SE, Koynov A, Goodey A, Heimbach T, Weissler VL, Leyssens C, Reynders T, Xu Z, Rottey S, Vargo R, Robertson MN, Stoch SA, Iwamoto M. Matthews RP, et al. Among authors: heimbach t. J Acquir Immune Defic Syndr. 2023 Apr 1;92(4):310-316. doi: 10.1097/QAI.0000000000003135. Epub 2022 Nov 29. J Acquir Immune Defic Syndr. 2023. PMID: 36450129 Free PMC article. Clinical Trial.
Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group.
Bauer A, Berben P, Chakravarthi SS, Chattorraj S, Garg A, Gourdon B, Heimbach T, Huang Y, Morrison C, Mundhra D, Palaparthy R, Saha P, Siemons M, Shaik NA, Shi Y, Shum S, Thakral NK, Urva S, Vargo R, Koganti VR, Barrett SE. Bauer A, et al. Among authors: heimbach t. Pharm Res. 2023 Jul;40(7):1601-1631. doi: 10.1007/s11095-022-03391-y. Epub 2023 Feb 22. Pharm Res. 2023. PMID: 36811809 Review.
Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report.
Wu F, Mousa Y, Raines K, Bode C, Tsang YC, Cristofoletti R, Zhang H, Heimbach T, Fang L, Kesisoglou F, Mitra A, Polli J, Kim MJ, Fan J, Zolnik BS, Sun D, Zhang Y, Zhao L. Wu F, et al. Among authors: heimbach t. CPT Pharmacometrics Syst Pharmacol. 2023 May;12(5):585-597. doi: 10.1002/psp4.12907. Epub 2023 Jan 4. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36530026 Free PMC article. Review.
74 results